HeartSciences (HSCS) Accumulated Expenses (2022 - 2026)
HeartSciences (HSCS) posted quarterly Accumulated Expenses of $300000.0 for Q2 2026, up 200.0% year-on-year from $100000.0 in Q2 2025, and up 68.89% on a QoQ basis from $177628.0 in Q4 2025.
HeartSciences (HSCS) Accumulated Expenses (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Accumulated Expenses for 5 consecutive years, with $300000.0 the latest figure, recorded in Q2 2026.
- Quarterly Accumulated Expenses rose 200.0% year-over-year to $300000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $300000.0 (up 200.0% YoY) and the FY2026 annual result came in at $300000.0, up 200.0% from the prior year.
- Accumulated Expenses rose to $300000.0 in Q2 2026 per HSCS's latest filing, from $177628.0 in the prior quarter.
- Over the last five years, Accumulated Expenses for HSCS reached as high as $1.1 million in Q2 2022 and fell as low as $100000.0 in Q2 2025.
- A 5-year average of $492439.5 and a median of $398331.0 in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Accumulated Expenses tumbled 74.9% — and 2026, when it soared 200.0%.
- Year by year, Accumulated Expenses stood at $890654.0 in 2022, then dropped by 13.25% to $772670.0 in 2023, then plunged by 52.16% to $369673.0 in 2024, then sank by 51.95% to $177628.0 in 2025, then soared by 68.89% to $300000.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $300000.0, $177628.0, and $311184.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 300,000.00 |
| Dec 31, 2025 | 177,628.00 |
| Oct 31, 2025 | 311,184.00 |
| Jul 31, 2025 | 599,287.00 |
| Apr 30, 2025 | 100,000.00 |
| Jan 31, 2025 | 315,890.00 |
| Oct 31, 2024 | 369,673.00 |
| Jul 31, 2024 | 331,098.00 |
| Apr 30, 2024 | 398,331.00 |
| Jan 31, 2024 | 584,427.00 |
| Oct 31, 2023 | 772,670.00 |
| Jul 31, 2023 | 630,979.00 |
| Apr 30, 2023 | 385,857.00 |
| Jan 31, 2023 | 644,610.00 |
| Oct 31, 2022 | 890,654.00 |
| Jul 31, 2022 | 505,547.00 |
| Apr 30, 2022 | 1.05 Mn |